Browsing Category
Croda
Product Substitution as a Way Forward in Avoiding Potentially Harmful Excipients in Neonates
28. April 2016
Our objectives were to explore the possibility of avoiding neonatal exposure to potentially harmful excipients of interest (EOI)—parabens, polysorbate 80, propylene glycol, benzoates, saccharin sodium, sorbitol and ethanol—through product substitution in Europe.…
Read More...
Read More...
STEP Database Updated – 40 Excipients now!
25. February 2016
The STEP stands for Safety and Toxicity of Excipients for Paediatrics. It is a user-designed resource developed by European Paediatric Formulation Initiative (EuPFI) and United States Paediatric Formulation Initiative (USPFI) in collaboration for storage and…
Read More...
Read More...
Potentially harmful excipients in neonatal medicines: a pan-European observational study
Objective: We aimed to describe administration of eight potentially harmful excipients of interest (EOI)-parabens, polysorbate 80, propylene glycol, benzoates, saccharin sodium, sorbitol, ethanol and benzalkonium chloride-to hospitalised neonates in Europe and to identify risk factors for…
Read More...
Read More...
Syloid® XDP silica – New Application Note on Solid delivery of PEG drug solubilizers –…
22. September 2015
Syloid® XDP silica: Carrier for liquid drug solubilizers in solid dosage form.
The solubility of poorly soluble drugs can be increased by using solubilizers such as polyethylene glycols (PEG), Tween 80 etc. These solublizers can be used to increase oral bioavailability…
Read More...
Read More...
Croda Obtains EXCiPACT Certification for Mevisa Site
Croda, an excipients supplier, announced that it has obtained EXCiPACT certification for its excipients manufacturing site at Mevisa, Spain.
Croda, an excipients supplier, announced that it has obtained EXCiPACT certification for its excipients manufacturing site at…
Read More...
Read More...